It is a broadly described annual report of Orion Pharma Limited in the year of 2013. The Company has contributed BDT 599.97 million to the government treasury in the form of the VAT, supplementary duty, advance income tax, tax on share premium etc during the financial year 2013 against the last year’s contribution of BDT 321.48 million, representing an increase of 86.63% over last year. The company attained consolidated net revenue of BDT 11,011.88 million during the year 2013 against last year’s achievement of BDT 9,546.32 million. Gross Profit BDT 925,868 million. Net Operating Profit BDT 412,954 million. Net profit before tax BDT 393,290 million. Net Profit after Tax for the year BDT 374,353 million. Consequently, the consolidated net profit after tax also declined in the reporting year compared to the previous year and basic earnings per share dropped from BDT 5.02 in corresponding period to BDT 4.06 in the financial year 2013.
The Board of Directors is pleased to propose and recommend for the declaration of Cash Dividend at the rate of @15% for approval of the shareholders for the year ended 31st December 2013. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Orion Pharma Limited:
